1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
-
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
Glodzik, Dominik LU ; Morganella, Sandro ; Davies, Helen R. ; Simpson, Peter T ; Li, Yilong ; Zou, Xueqing ; Diez-Perez, Javier ; Staaf, Johan LU
; Alexandrov, Ludmil B.
and Smid, Marcel
, et al.
(2017)
In Nature Genetics
49(3).
p.341-348
Mark
-
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Davies, Helen R. ; Glodzik, Dominik LU ; Morganella, Sandro ; Yates, Lucy R. ; Staaf, Johan LU
; Zou, Xueqing
; Ramakrishna, Manasa
; Martin, Sancha
; Boyault, Sandrine
and Sieuwerts, Anieta M.
, et al.
(2017)
In Nature Medicine
23(4).
p.517-525
Mark
- Societal challenges of precision medicine : Bringing order to chaos
- Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
- 2016
- Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
- The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
- Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
- Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
- 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer